Due to the expression of PRC2 components (EZH2, EED, and SUZ12) in both non-CRC and CRC cells (Figure 4B), it is plausible that EZH2's activity or target gene selection might be specifically modulated by additional factors. The gene discussed is EZH2; the disease is colorectal carcinoma.